gated Archives | ArisGlobal

Gain the Decision Advantage

Breakthrough 2027 brings together life sciences leaders, industry regulators and experts, to explore the future of AI in life sciences.

Driving Cross-Domain R&D Insights with Meaning-Aware AI

In this webinar, discover how a unified decision intelligence layer across R&D can connect data, understand context, and harness institutional knowledge to enable faster, more confident, and more transparent decision-making.

Harness AI in Safety – Without the Risk: A Practical Checklist

In our practical checklist, we walk through the most important criteria to consider when evaluating AI solutions and technology partners, helping you build a future-ready Regulatory strategy.

The AI Integration Roadmap for Pharmacovigilance

In our guide, we outline the key considerations life sciences organizations should address when building and scaling an AI strategy in PV.

Leveraging Conversational AI for Intelligent Adverse Event and Product Complaint Intake

Discover how to take advantage of agentic AI capabilities that bring fragmented safety evidence together, accelerate signal validation, and help safety teams move from manual review to proactive risk management.

Building AI Success in Regulatory Affairs: A Practical Checklist

The Rise of Intelligence Agents

Introducing Agentic AI for Signal Management

AI-Powered Regulatory Intelligence Checklist

In our checklist, we outline the most important criteria that leading organizations are keeping in mind when evaluating Agentic AI-powered regulatory intelligence solutions.

Accelerating RIM System Compliance with AI and Sporify

Discover how to take advantage of modular AI offerings that make it simple to track global regulatory changes and accelerate SPOR and ISO IDMP compliance.

Modernizing Front-End Patient Data Collection Checklist

In our checklist, we walk through the most important criteria to keep in mind when evaluating AI-driven data collection and reporting solutions.

ArisGlobal is a pivotal partner in the life sciences industry, specializing in solutions that drive drug development, safety monitoring, and regulatory compliance. We collaborate with more than 220 global life sciences companies, CROs, and government health authorities, including leading biopharmaceutical firms and regulatory bodies such as FDA, Health Canada, and NMPA.

Headquartered in the United States, ArisGlobal has regional offices in Europe, India, Japan and China.